FINHUB Insights

Language: EN
Sign in Sign up

Revvity Q1 FY26: where the revenue came from and where it went

The whole income statement of Revvity for this quarter, as one diagram: what earned the revenue, and what it went on.

Period
Dec 29, 2025 – Apr 5, 2026
Reported
May 12, 2026 10-Q accession 0000031791-26-000019

Revenue$0.71B +7% year over year
Gross profit$0.39B 55% margin
Operating profit$0.08B 11% margin
Net profit$0.04B 6% margin
100% free

It's free. All of it.

A free account opens every diagram. We send one link to confirm your address, and that is the whole of it.

Continue with Google Create a free account

Already have an account? Sign in

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Apr 5, 2026).
ItemValueShare of revenueYear over year
Revenue 0.71 100% +7%
Life sciences 0.36 51% +6%
Diagnostics 0.35 49% +8%
Cost of revenue−0.3245%
Gross profit0.3955% margin−2pp
R&D−0.068%+0pp
SG&A−0.2536%−2pp
Operating profit0.0811% margin+0pp
Interest & other costs−0.03
Tax−0.01
Net profit0.04 6% margin−1pp

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Filing on EDGAR More quarters of RVTY

55 of 418 companies, most recently reported first